knowledg
infecti
diseas
emerg
genom
proteom
epidemiolog
clinic
data
provid
insight
mechan
immun
function
diseas
pathogenesi
epidemiolog
describ
consider
advanc
comput
method
data
mine
mathemat
model
epidemiolog
simul
use
enhanc
understand
infecti
agent
discuss
impact
discoveri
new
therapeut
control
spread
epidem
pandem
outbreak
infecti
diseas
occur
throughout
human
histori
ancient
time
athenian
plagu
bc
reportedli
kill
onehalf
popul
athen
justinian
plagu
ad
result
million
death
black
death
account
million
death
worldwid
chang
socioeconom
demograph
environment
factor
led
resurg
old
new
infecti
diseas
past
decad
world
wit
increas
problem
drugresist
pathogen
diseas
malaria
tuberculosi
also
emerg
new
pathogen
includ
rotaviru
human
immunodefici
viru
hiv
hepat
c
viru
hantaviru
sever
acut
respiratori
syndrom
coronaviru
sarscov
reemerg
epidem
chikungunya
viru
chikv
previous
known
benign
diseas
africa
indian
ocean
southeast
asia
pacif
past
decad
caus
sever
morbid
fatal
recent
april
tripl
reassort
influenza
virus
contain
gene
human
swine
avian
influenza
virus
appear
spread
countri
oversea
territori
commun
caus
death
cours
one
year
earliest
time
human
striven
understand
behavior
infecti
organ
mechan
govern
diseas
transmiss
goal
profoundli
shape
modern
knowledg
emerg
reemerg
infect
recent
comput
techniqu
led
way
new
era
enabl
rapid
largescal
analys
pathogen
possibl
use
tradit
experiment
techniqu
survey
method
mathemat
model
epidemiolog
comput
biolog
bioinformat
use
studi
infecti
diseas
discuss
work
translat
benefit
humankind
particularli
molecular
epidemiolog
design
novel
therapeut
mathemat
model
routin
use
studi
spread
control
infecti
diseas
histori
mathemat
epidemiolog
could
trace
daniel
bernoulli
formul
model
evalu
effect
variol
healthi
peopl
smallpox
viru
start
centuri
howev
mathemat
model
appli
studi
transmiss
pattern
infecti
diseas
first
use
understand
recurr
measl
epidem
incid
control
malaria
sinc
epidemiolog
model
grown
rapidli
fuel
advent
special
databas
tabl
focus
pathogen
gene
method
incorpor
success
environment
manag
program
develop
intervent
measur
contain
strategi
design
new
therapeut
agent
other
plan
experi
hypothes
test
sever
statist
measur
use
frequent
quantifi
diseas
popul
facilit
diseas
manag
tabl
one
measur
incid
diseas
defin
rate
new
case
occur
popul
risk
specifi
time
period
realiti
popul
risk
constantli
chang
birth
death
migrat
measur
might
good
reflect
true
incid
diseas
one
way
solv
relat
number
new
case
person
year
risk
comput
sum
time
individu
member
popul
risk
measur
period
anoth
commonli
use
measur
preval
diseas
proport
infect
popul
given
point
time
often
use
altern
incid
case
sampl
size
small
diseas
high
mortal
rate
research
interest
calcul
case
fatal
rate
cfr
proport
infect
patient
die
certain
diseas
specifi
period
instanc
epidemiolog
investig
patient
sarscov
infect
hong
kong
report
april
estim
cfr
patient
younger
year
patient
age
year
older
use
link
mortal
morbid
help
measur
variou
aspect
properti
diseas
pathogen
sever
virul
anoth
import
factor
research
clinician
interest
clinic
attack
rate
proport
infect
patient
symptom
diseas
estim
median
clinic
attack
rate
russian
flu
pandem
cfr
rang
statist
measur
exist
review
elsewher
understand
diseas
transmit
one
person
next
spread
popul
import
assess
risk
infect
contact
trace
build
conting
plan
contain
outbreak
air
travel
play
import
part
spread
infecti
diseas
transmiss
mycobacterium
tuberculosi
sarscov
influenza
viru
within
drug
discoveri
today
volum
number
januari
review
rel
risk
probabl
event
occur
expos
group
probabl
event
occur
nonexpos
group
confin
space
airplan
cabin
well
document
comput
analysi
interregion
influenza
spread
usa
shown
intern
air
travel
might
affect
onset
diseas
outbreak
studi
epidem
pattern
season
influenza
outbreak
usa
team
conclud
air
travel
flow
period
time
suffici
propag
epidem
throughout
usa
suggest
realist
model
spread
epidem
interst
level
might
need
take
air
transport
account
yet
histori
shown
air
travel
restrict
would
limit
effect
outbreak
russian
flu
pandem
spread
across
europ
usa
within
four
month
despit
slower
surfac
travel
much
smaller
travel
flow
mathemat
model
made
possibl
us
comput
speed
diseas
transmiss
shown
recent
valleron
et
al
estim
rate
kmweek
europ
kmweek
usa
sever
comput
simul
experi
spread
pandem
influenza
also
conclud
air
travel
restrict
would
limit
impact
compar
local
control
measur
explan
might
speed
pandem
depend
passeng
flow
citi
degre
connected
citi
network
attempt
also
made
analyz
diseas
spread
within
urban
environ
quantifi
rel
import
differ
mode
transport
region
spread
influenza
epidem
evalu
intervent
strategi
isol
household
quarantin
school
workplac
closur
travel
restrict
mass
screen
key
control
node
includ
sea
port
airport
similar
relat
sequenc
give
clue
structur
function
homolog
common
ancestor
comput
method
align
sequenc
featur
therefor
particularli
use
multipl
sequenc
align
method
organ
sequenc
dna
rna
protein
identifi
region
similar
might
help
explain
function
andor
phenotyp
variabl
flu
first
human
pandem
caus
influenza
virus
share
common
ancestri
russian
flu
kill
approxim
million
peopl
spanish
flu
reportedli
affect
approxim
global
popul
kill
least
million
peopl
worldwid
asian
flu
result
approxim
million
death
hong
kong
flu
caus
approxim
million
death
case
ancestri
unclear
multipl
sequenc
align
method
use
infer
phylogenet
relationship
fig
includ
identifi
global
optim
align
solut
studi
highli
conserv
sequenc
also
identifi
maxim
homolog
subsequ
among
set
long
sequenc
detect
distantli
relat
protein
appli
phylogenet
analysi
rapidli
evolv
virus
hiv
bhattacharya
et
al
shown
viral
escap
effect
instead
immun
escap
often
explain
appar
human
leukocyt
antigen
hla
mediat
immuneescap
mutat
defin
older
analysi
method
relat
concept
use
inform
theori
quantifi
variabl
pathogen
sequenc
theoret
statist
inform
entropi
measur
rate
inform
transfer
biolog
sequenc
use
method
recent
analyz
chikv
proteom
introduct
result
indic
larg
amount
antigen
switch
ie
chang
gene
express
specif
site
might
abrog
bind
hla
molecul
interfer
tcell
respons
lead
cellular
immun
evas
cluster
chikv
genom
also
sever
attempt
identifi
amino
acid
residu
like
involv
viru
adapt
exampl
find
interdepend
mutat
multipl
protein
miotto
et
al
appli
mutual
inform
inform
theoret
statist
measur
strength
associ
pair
variabl
identifi
characterist
site
influenza
protein
human
isol
present
conserv
mutat
catalogu
characterist
site
eight
intern
protein
creat
sequenc
use
deriv
adapt
signatur
influenza
proteom
novel
develop
sequenc
analysi
evolv
recent
spatiotempor
analysi
infecti
diseas
evolut
typic
sequenc
analysi
perform
collect
biolog
sequenc
assum
share
evolutionari
relationship
howev
flood
publicli
avail
newli
gener
pathogen
sequenc
annot
host
organ
time
isol
countri
origin
open
possibl
incorpor
paramet
studi
microbi
pathogen
evolut
sheng
et
al
recent
shown
geograph
time
inform
public
biolog
databas
could
integr
patternmin
algorithm
studi
antigen
chang
influenza
virus
likelihood
one
viru
abl
mutat
anoth
form
depend
whether
exist
within
certain
time
period
connect
locat
collect
sequenc
similar
method
use
trace
evolut
trajectori
subtyp
asia
usa
europ
differ
time
point
attempt
unifi
epidemiolog
evolutionari
process
drive
spatiotempor
incid
phylogenet
pattern
differ
scale
also
report
instanc
grenfel
et
al
introduc
phylodynam
framework
studi
pathogen
genet
variat
modul
host
immun
transmiss
bottleneck
epidem
dynam
affect
divers
epidemiolog
phylogenet
pattern
measl
influenza
virus
hiv
dengu
hepat
c
viru
epidem
behavior
pathogen
could
qualit
examin
analyz
evolutionari
inertia
within
focal
popul
one
approach
estim
natur
select
nucleotid
usag
singl
amino
acid
site
degeneraci
genet
code
point
mutat
silent
amino
acid
replac
neutral
theori
molecular
evolut
first
introduc
kimura
state
nucleotid
substitut
select
neutral
fix
random
genet
drift
synonym
silent
substitut
primarili
transpar
natur
select
wherea
nonsynonym
replac
substitut
might
due
strong
select
pressur
compar
fixat
rate
nonsynonym
n
synonym
substitut
help
assess
extent
adapt
evolut
highli
variabl
genet
loci
n
ratio
v
otherwis
known
accept
rate
provid
sensit
measur
select
pressur
amino
acid
level
v
indic
neutral
expect
v
suggest
neg
purifi
select
v
suggest
posit
diversifi
select
group
gene
often
show
v
relationship
antigen
gene
plasmodia
parasit
use
relaxedclock
phylogenet
model
estim
absolut
rate
synonym
nonsynonym
substitut
time
lemey
et
al
show
diseas
progress
among
patient
predict
synonym
substitut
rate
wherea
nonsynonym
rate
evolv
within
patient
consequ
chang
antibodi
select
pressur
hemagglutinin
gene
influenza
viru
probabl
one
fastest
evolv
gene
term
rate
nucleotid
substitut
estim
per
site
per
year
gene
highli
variabl
enhanc
pathogen
abil
evad
host
defens
simpl
count
method
nei
gojobori
often
use
estim
n
howev
reliabl
approach
low
rate
transit
nucleotid
chang
higher
transversion
chang
modelbas
maximum
likelihood
method
propos
muse
gaut
goldman
yang
viabl
wide
use
altern
purpos
origin
maximum
likelihood
model
goldman
yang
assum
singl
v
lineag
site
extend
account
variat
allow
v
vari
across
lineag
among
substitut
site
among
site
among
lineag
lineagespecif
model
assum
v
valu
vari
among
site
detect
posit
select
lineag
averag
n
site
greater
averag
sitespecif
model
convers
allow
v
vari
among
site
among
lineag
model
detect
posit
select
individu
site
averag
n
lineag
greater
averag
allow
v
vari
among
site
among
lineag
extend
goldman
yang
model
could
appli
detect
posit
select
occur
multipl
time
point
affect
multipl
site
pathogenesi
multistep
process
continu
crosstalk
invad
pathogen
human
host
abil
invas
parasit
infiltr
mammalian
host
requir
cell
surfac
contact
host
target
molecul
interact
take
place
specif
receptormedi
mechan
could
lead
lysi
host
target
cell
substrat
immun
system
come
play
pathogen
infiltr
infect
host
use
layer
defens
mechan
increas
specif
take
form
innat
andor
adapt
immun
array
immun
receptor
includ
mast
cell
phagocyt
basophil
natur
killer
cell
cell
b
cell
comput
method
support
vector
machin
predict
proteinprotein
interact
ppi
ppi
network
therefor
use
identifi
effector
protein
associ
host
infect
also
discov
host
immun
molecul
involv
clearanc
pathogen
fig
identif
novel
interact
plasmodium
falciparum
human
protein
recent
report
dyer
et
al
p
falciparum
one
four
distinct
speci
malaria
parasit
infect
human
parasit
respons
least
million
infect
million
death
year
use
bayesian
statist
team
identifi
p
falciparumhuman
protein
interact
sever
function
enrich
subnetwork
could
serv
start
point
therapeut
develop
role
nfkb
regul
gene
express
analyz
shelest
et
al
use
pseudomona
aeruginosa
model
organ
gene
screen
use
weight
matric
potenti
new
target
gene
identifi
attempt
also
made
simul
human
immun
system
system
level
good
exampl
eufund
immunogrid
project
aim
develop
virtual
human
immun
system
reflect
divers
rel
proport
constitu
molecul
cell
antivir
drug
could
essenc
target
either
cellular
protein
viral
protein
drug
target
cellular
protein
could
activ
spectrum
unrel
virus
mani
exampl
ppi
subnetwork
might
activ
chikv
infect
predict
use
support
vector
machin
model
support
vector
machin
system
train
use
gene
ppi
deriv
biogrid
kegg
netpath
mint
dip
inact
reactom
ambion
sabiosci
cluster
implic
inflammatori
respons
cluster
b
e
nfkb
pathway
cluster
c
regul
ubiquitinprotein
ligas
activ
cluster
cytokin
chemokin
signal
pathway
cluster
f
jakstat
cascad
mediat
factor
link
cluster
includ
cluster
nfkbia
cluster
b
cluster
c
cluster
cluster
ifna
cluster
f
cellular
protein
use
differ
virus
replic
compound
might
less
possibl
resist
develop
might
lead
increas
risk
toxic
contrast
drug
target
viral
protein
like
specif
less
toxic
natur
narrow
spectrum
action
higher
likelihood
viral
drug
resist
life
cycl
typic
viru
consist
sever
stage
viru
attach
host
cell
releas
progeni
virion
cell
one
could
target
specif
process
viral
infect
includ
viru
attach
uncoat
viral
rna
replic
viral
protein
synthesi
process
use
structureguid
design
method
import
identifi
select
protein
target
well
identifi
hit
screen
fragment
fig
discoveri
novel
natur
inhibitor
human
rhinoviru
hrv
coat
protein
use
structureguid
search
method
describ
rolling
et
al
hrv
small
nonenvelop
singlestrand
rna
enterovirus
belong
picornavirida
famili
viral
capsid
protein
contain
hydrophob
pocket
occupi
pocket
factor
displac
pocket
factor
small
antivir
compound
could
trigger
conform
chang
capsid
protein
prevent
viru
uncoat
andor
attach
cell
surfac
structureguid
search
base
featur
characterist
ligand
bind
hydrophob
pocket
perform
databas
plant
metabolit
endow
antivir
activ
strategi
eventu
led
discoveri
asafetida
constitu
compound
select
inhibitori
activ
hrv
serotyp
structureguid
lead
discoveri
initi
target
viral
protein
also
report
includ
dengu
viru
envelop
protein
hiv
type
integras
hepat
c
viru
rnadepend
rna
polymeras
select
antigen
could
induc
effect
protect
respons
difficult
combinatori
natur
human
immun
system
larg
repertoir
immunoglobulin
tcell
receptor
known
exist
gener
mechan
combinatori
divers
variabl
divers
join
gene
ndivers
immunoglobulin
somat
hypermut
hla
allel
report
date
fulli
heterogen
person
inherit
six
differ
hla
class
allel
equal
number
class
ii
allel
theoret
number
hla
haplotyp
greater
addit
number
tcell
epitop
candid
mani
bcell
epitop
candid
known
exist
earli
day
vaccin
primarili
develop
use
dead
weaken
form
pathogen
recent
past
two
decad
advanc
inform
technolog
provid
basi
systemat
discoveri
immunogen
epitop
subunit
peptidebas
vaccin
design
much
emphasi
place
comput
identifi
evolutionarili
conserv
amino
acid
sequenc
pathogen
proteom
immunolog
relev
potenti
tcell
epitop
epitop
could
offer
broader
protect
across
divers
subtyp
particularli
use
pathogen
pandem
potenti
influenza
viru
anoth
approach
identifi
promiscu
peptid
could
bind
wide
repertoir
hla
molecul
make
sure
frequent
hla
molecul
bind
least
one
peptid
vaccin
cocktail
method
enabl
design
broadbas
peptid
vaccin
improv
popul
coverag
hallingbrown
et
al
shown
vaccin
antigen
contain
fewer
predict
hlabind
peptid
control
bacteri
protein
subcellular
locat
third
strategi
would
thu
identifi
protein
contain
singl
immunodomin
epitop
much
effort
also
devot
develop
tool
help
identifi
bcell
epitop
antigen
sequenc
bcell
epitop
either
linear
conform
natur
although
bcell
epitop
linear
subject
intens
interest
recent
year
consid
easier
exampl
roadmap
structurebas
virtual
screen
campaign
structurebas
screen
campaign
usual
compris
follow
step
target
select
ii
librari
prepar
iii
stereochem
qualiti
assess
iv
comput
model
v
admetox
assess
vi
comput
optim
wwwdrugdiscoverytodaycom
design
conform
counterpart
silico
screen
smallmolecul
chemokin
antagonist
also
report
use
discoveri
vaccin
adjuv
augment
human
tcell
prolifer
discuss
way
mathemat
model
epidemiolog
comput
biolog
bioinformat
use
better
understand
infecti
agent
although
first
mathemat
model
epidemiolog
report
took
one
half
centuri
determinist
epidemiolog
take
centuri
wide
embrac
rapid
growth
varieti
analyt
tool
increas
avail
larg
volum
genom
function
clinic
epidemiolog
data
scientif
literatur
public
databas
clinic
record
midst
golden
era
infecti
diseas
research
one
import
challeng
integr
method
variou
technolog
advanc
make
sens
data
gener
use
techniqu
next
year
expect
sophist
method
emerg
enabl
integr
data
analysi
higher
level
experiment
design
enhanc
understand
molecular
biolog
pathogenesi
infecti
diseas
also
enabl
design
nextgener
diagnost
therapeut
new
control
strategi
contain
spread
